These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2091382)

  • 1. [Guanfacine in the treatment of arterial hypertension in diabetics].
    Monova D; Daskalova I; Belovezhdov N
    Vutr Boles; 1990; 29(6):44-7. PubMed ID: 2091382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of 5-month guanfacine treatment on the renin-angiotensin-aldosterone system and some metabolic factors in patients with diabetes mellitus type II and hypertension].
    Jaromczyk-Slisz J; Kubasik A; Jasiel-Wojculewicz H; Badzio T; Krupa-Wojciechowska B
    Pol Tyg Lek; 1992 Nov 16-30; 47(46-48):1045-7. PubMed ID: 1305723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
    Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
    Mayer O; Polívková H
    Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estulic--a well tolerated and effective antihypertensive drug in general practice.
    Török K
    Ther Hung; 1992; 40(2):79-82. PubMed ID: 1462281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estulic monotherapy and combined antihypertensive therapy.
    Faluhelyi A; Szentkereszty A
    Ther Hung; 1991; 39(2):87-9. PubMed ID: 1948783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
    Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
    Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
    Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H
    Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension.
    Schwartz SL; Hanson C; Lucas C; Rosenblatt S; Rosenstock J; Whittier F; Wistran D; Riche C; Mulcahy WS
    Clin Ther; 1993; 15(1):79-87. PubMed ID: 8458057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estulic in the long-term treatment of hypertension].
    Rhomberg F
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1922-4. PubMed ID: 6782668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estulic (guanfacine) in the treatment of arterial hypertension].
    Erina EV; Beliakova EV; Charyev KhE
    Ter Arkh; 1992; 64(8):36-9. PubMed ID: 1440392
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypotensive and anti-ischemic efficiency of estulic in course treatment of myocardial infarction complicated by essential hypertension].
    Tepliakov AT; Braslavskaia TG; Alugishvili MZ; Karpov RS
    Ter Arkh; 1999; 71(8):27-30. PubMed ID: 10515031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Captopril from Pharmachem in the treatment of arterial hypertension].
    Monova D; Belovezhdov N
    Vutr Boles; 1989; 28(3):40-3. PubMed ID: 2672594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
    Coves MJ; Gomis R; Casamitjana R; Lienas V; Vilaradell E
    J Med; 1989; 20(3-4):291-6. PubMed ID: 2572660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The benefits of L-carnitine therapy in essential arterial hypertension with diabetes mellitus type II].
    Digiesi V; Palchetti R; Cantini F
    Minerva Med; 1989 Mar; 80(3):227-31. PubMed ID: 2654758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of hypertension patients with Estulic].
    Baliakina EV; Anuchin VV; Patrusheva IF; Iurenev AP
    Ter Arkh; 1996; 68(12):57-60. PubMed ID: 9054043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.